News from eicosis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 17, 2020, 08:00 ET EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026

EicOsis Human Health, a pharmaceutical company developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide...

Apr 09, 2020, 09:00 ET EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain

EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase...

Dec 10, 2019, 12:00 ET EicOsis Announces First Subject Dosed in Phase 1a Clinical Trial of EC5026

EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase...

Oct 30, 2019, 09:00 ET EicOsis Awarded SBIR Grant from the NCI/NIH to Evaluate the Potential of Drug Candidate, EC5026, to Treat Cancer-associated Pain

EicOsis LLC, a pharmaceutical company developing a new oral non-narcotic analgesic, announced today it has been awarded a $268,000 Small Business...

Oct 15, 2019, 08:00 ET EicOsis receives $15MM grant from the National Institute of Drug Abuse to help fund trials of non-opioid pain therapy

The National Institute on Drug Abuse (NIDA) has awarded a grant to EicOsis LLC as part of the NIH initiative Helping to End Addiction Long-Term (HEAL ...